Boulder, CO · Founded 2019 · Privately Held (backing)
Developer of a drug analysis platform designed to capitalize on the chemical diversity and evolutionary significance of natural samples. Enveda is based in Boulder, CO and was founded in 2019. It was valued at $2 billion at its Series E in Sep 2026, the last priced event on record. It has raised $530 million across 1 recorded round; the latest was a $311 million Series E in Sep 2026.
PMV mark · valuation
$2.0B
Oct 2026
Priced at
its Series E
Sep 2026
Total raised
$530.0M
Last round
Series E
Sep 2026
Team — not yet on record
No current team members for Enveda are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Enveda with a free account
·The post-money valuation on its round
·The complete investor list: 47 names
·Watch Enveda: the Monday email on marks, rounds and moves
